IDT Australia

Overview

IDT Australia is a contract development and manufacturing organization (CDMO) providing end-to-end cGMP solutions for pharmaceutical development and commercialization. The company supports clients from pre-clinical research through commercial production, with particular expertise in small molecule APIs, specialty oral dosage forms, and advanced sterile therapies.

Core Service Lines

Active Pharmaceutical Ingredients (APIs)

• Small molecule API expertise
• Highly potent and cytotoxic compound manufacturing
• Pre-clinical to commercial scale production
• Linker-payload manufacture for antibody-drug conjugates (ADCs)

Specialty Orals

• Formulation and production of solid oral dosage forms
• Tablets and capsules
• Non-sterile liquid products
• Schedule 8 and 9 drug products (controlled substances)

Advanced Therapies & Sterile Manufacturing

• Advanced sterile fill and finish into vials
• Lyophilization services
• Radiopharmaceutical manufacturing

Integrated Support Services

• Research & Development
• Analytical and microbiological testing
• ICH stability testing
• Labelling and packaging
• Project management
• Supply chain and distribution
• Regulatory support

Quality & Regulatory

The company operates under global accreditation standards and maintains cGMP compliance. Manufacturing standards meet highest international benchmarks. IDT Australia leverages Australia's streamlined regulatory pathways and R&D Tax Incentive (up to 43.5% refundable cash benefit for eligible projects) to accelerate client development timelines.